CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Series E Cumulative Redeemable Preferred Stock Preferred Stock	Series E Cumulative Redeemable Preferred Stock Additional Paid In Capital	Series E Cumulative Redeemable Preferred Stock Cumulative dividends and distributions	Series E Cumulative Redeemable Preferred Stock	Series F Cumulative Redeemable Preferred Stock Cumulative dividends and distributions	Series F Cumulative Redeemable Preferred Stock	Series G Cumulative Redeemable Preferred Stock Preferred Stock	Series G Cumulative Redeemable Preferred Stock Additional Paid In Capital	Series G Cumulative Redeemable Preferred Stock Cumulative dividends and distributions	Series G Cumulative Redeemable Preferred Stock	Series H Cumulative Redeemable Preferred Stock Preferred Stock	Series H Cumulative Redeemable Preferred Stock Additional Paid In Capital	Series H Cumulative Redeemable Preferred Stock Cumulative dividends and distributions	Series H Cumulative Redeemable Preferred Stock	Series I Cumulative Redeemable Preferred Stock Cumulative dividends and distributions	Series I Cumulative Redeemable Preferred Stock	Preferred Stock	Common Stock	Additional Paid In Capital	Retained Earnings	Cumulative dividends and distributions	Non-Controlling Interest in Consolidated Joint Venture	Total
Beginning Balance at Dec. 31, 2020																	$ 190,000	$ 2,156	$ 2,586,108	$ 913,766	$ (1,643,386)	$ 40,735	$ 2,089,379
Beginning Balance (in shares) at Dec. 31, 2020																	7,600,000	215,593,401
Increase (Decrease) in Stockholders' Equity
Amortization of deferred stock compensation																			2,869				2,869
Issuance of restricted common stock, net																		$ 6	(3,522)				(3,516)
Issuance of restricted common stock, net (in shares)																		581,683
Preferred stock dividends and dividends payable			$ (1,998)	$ (1,998)	$ (1,209)	$ (1,209)
Contribution from noncontrolling interest																						1,375	1,375
Net income (loss)																				(53,312)		(1,975)	(55,287)
Ending Balance at Mar. 31, 2021																	$ 190,000	$ 2,162	2,585,455	860,454	(1,646,593)	40,135	2,031,613
Ending Balance (in shares) at Mar. 31, 2021																	7,600,000	216,175,084
Beginning Balance at Dec. 31, 2020																	$ 190,000	$ 2,156	2,586,108	913,766	(1,643,386)	40,735	2,089,379
Beginning Balance (in shares) at Dec. 31, 2020																	7,600,000	215,593,401
Increase (Decrease) in Stockholders' Equity
Net income (loss)																							(83,205)
Ending Balance at Jun. 30, 2021																	$ 256,250	$ 2,190	2,626,582	833,132	(1,654,388)	39,539	2,103,305
Ending Balance (in shares) at Jun. 30, 2021																	10,250,000	219,043,105
Beginning Balance at Mar. 31, 2021																	$ 190,000	$ 2,162	2,585,455	860,454	(1,646,593)	40,135	2,031,613
Beginning Balance (in shares) at Mar. 31, 2021																	7,600,000	216,175,084
Increase (Decrease) in Stockholders' Equity
Amortization of deferred stock compensation																			4,784				4,784
Issuance of restricted common stock, net																		$ (1)	(1,360)				(1,361)
Issuance of restricted common stock, net (in shares)																		(45,661)
Preferred stock dividends and dividends payable			(1,554)	(1,554)	$ (1,209)	$ (1,209)			$ (292)	$ (292)			$ (724)	$ (724)
Net proceeds from issuance of common stock																		$ 29	37,630				37,659
Number of shares of common stock issued (in shares)																		2,913,682
Net issuance of preferred stock in connection with hotel acquisition							$ 66,250	$ (142)		66,108
Net issuance of preferred stock in connection with hotel acquisition (in shares)							2,650,000
Net proceeds from issuance of preferred stock											$ 115,000	$ (3,801)		111,199
Number of shares of preferred stock issued (in shares)											4,600,000
Redemption of preferred stock	$ (115,000)	$ 4,016	$ (4,016)	$ (115,000)
Redemption of preferred stock (in shares)	(4,600,000)
Net income (loss)																				(27,322)		(596)	(27,918)
Ending Balance at Jun. 30, 2021																	$ 256,250	$ 2,190	2,626,582	833,132	(1,654,388)	39,539	2,103,305
Ending Balance (in shares) at Jun. 30, 2021																	10,250,000	219,043,105
Beginning Balance at Dec. 31, 2021																	$ 281,250	$ 2,193	2,631,484	948,064	(1,664,024)	40,807	2,239,774
Beginning Balance (in shares) at Dec. 31, 2021																	11,250,000	219,333,783
Increase (Decrease) in Stockholders' Equity
Amortization of deferred stock compensation																			3,701				3,701
Issuance of restricted common stock, net																		$ 2	(3,353)				(3,351)
Issuance of restricted common stock, net (in shares)																		213,179
Preferred stock dividends and dividends payable									(587)	(587)			(1,761)	(1,761)	$ (1,425)	$ (1,425)
Repurchases of outstanding common stock																		$ (38)	(43,427)				(43,465)
Repurchases of outstanding common stock (in shares)																		(3,879,025)
Net income (loss)																				13,989		1,134	15,123
Ending Balance at Mar. 31, 2022																	$ 281,250	$ 2,157	2,588,405	962,053	(1,667,797)	41,941	2,208,009
Ending Balance (in shares) at Mar. 31, 2022																	11,250,000	215,667,937
Beginning Balance at Dec. 31, 2021																	$ 281,250	$ 2,193	2,631,484	948,064	(1,664,024)	40,807	2,239,774
Beginning Balance (in shares) at Dec. 31, 2021																	11,250,000	219,333,783
Increase (Decrease) in Stockholders' Equity
Net income (loss)																							52,815
Ending Balance at Jun. 30, 2022																	$ 281,250	$ 2,125	2,494,238	997,402	(1,671,570)		2,103,445
Ending Balance (in shares) at Jun. 30, 2022																	11,250,000	212,450,788
Beginning Balance at Mar. 31, 2022																	$ 281,250	$ 2,157	2,588,405	962,053	(1,667,797)	41,941	2,208,009
Beginning Balance (in shares) at Mar. 31, 2022																	11,250,000	215,667,937
Increase (Decrease) in Stockholders' Equity
Amortization of deferred stock compensation																			2,971				2,971
Forfeiture of restricted common stock (in shares)																		(34,807)
Preferred stock dividends and dividends payable									$ (587)	$ (587)			$ (1,761)	$ (1,761)	$ (1,425)	$ (1,425)
Distribution to noncontrolling interest																						(5,500)	(5,500)
Issuance of restricted common stock																		$ 1	(92)				(91)
Issuance of restricted common stock (in shares)																		53,616
Repurchases of outstanding common stock																		$ (33)	(34,482)				(34,515)
Repurchases of outstanding common stock (in shares)																		(3,235,958)
Acquisition of noncontrolling interest, net																			(62,564)			(38,784)	(101,348)
Net income (loss)																				35,349		$ 2,343	37,692
Ending Balance at Jun. 30, 2022																	$ 281,250	$ 2,125	$ 2,494,238	$ 997,402	$ (1,671,570)		$ 2,103,445
Ending Balance (in shares) at Jun. 30, 2022																	11,250,000	212,450,788